Jarrod Longcor serves as Executive at Cellectar Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Jarrod Longcor has executed 9 insider transactions totaling $181.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 2, 2025 involved purchasing 10,000 shares valued at $49.9K.
Jarrod Longcor currently holds 12,768 shares of Cellectar Biosciences, Inc. (CLRB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jarrod Longcor has been a net buyer of CLRB stock. They have purchased $166.5K and sold $15.3K worth of shares.
Jarrod Longcor's most recent insider trade was on Jul 2, 2025, when they purchased 10,000 shares at $4.99 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 28, 2020 | CLRB | $40.0K | Purchase | 29,630 | $1.35 | Discretionary |
| Jun 5, 2020 | CLRB | $75.0K | Purchase | 65,218 | $1.15 | Discretionary |
| Feb 3, 2020 | CLRB | $108.4K | Award | 40,000 | $2.71 | Discretionary |
| Feb 28, 2019 | CLRB | $200 | Purchase | 100 | $2.00 | Discretionary |
| Aug 16, 2018 | CLRB | $1.4K | Purchase | 500 | $2.71 | Discretionary |
| Mar 13, 2018 | CLRB | $15.3K | Sale | 13,000 | $1.18 | Discretionary |
| Apr 18, 2017 | CLRB | $0 | Award | 80,000 | $N/A | Discretionary |